Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Cara Therapeutics (CARA)

Cara Therapeutics (CARA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cara Therapeutics 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 USA

P: 203-406-3700

Description:

Cara Therapeutics, Inc. is a biopharmaceutical company. The company is focused on developing and commercializing new chemical entities designed to alleviate pain. Cara Therapeutics, Inc. is based in Shelton, United States.

Key Statistics

Overview:

Market Capitalization, $K 671,138
Enterprise Value, $K 504,108
Shares Outstanding, K 53,734
Annual Sales, $ 23,030 K
Annual Net Income, $ -88,440 K
Last Quarter Sales, $ 10,810 K
Last Quarter Net Income, $ -23,180 K
60-Month Beta 0.99
% of Insider Shareholders 3.20%
% of Institutional Shareholders 65.00%
Float, K 52,015
% Float 96.80%
Short Volume Ratio 0.62

Growth:

1-Year Return 1.46%
3-Year Return -24.62%
5-Year Return -1.73%
5-Year Revenue Growth 25,488.89%
5-Year Earnings Growth 17.14%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.43 on 11/07/22
Next Earnings Date N/A
Earnings Per Share ttm -1.66
EPS Growth vs. Prev Qtr -437.50%
EPS Growth vs. Prev Year -2,050.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

CARA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -43.13%
Return-on-Assets % -38.87%
Profit Margin % -384.02
Net Margin % N/A
Debt/Equity 0.00
Price/Sales 29.80
Price/Cash Flow N/A
Price/Book 3.48
Book Value/Share 3.44
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar